Re:Is employer-based health insurance a barrier to entrepren...
by khafra on Monday February 28, 2011 @12:42PM
(#2272025)
...and the way to encourage research into SCA is to make sure most people that suffer from it are unable to pay for whatever treatment gets developed, by denying them healthcare? You've made the point that some diseases disproportionately affect minorities, but the step that gets us from "unaffordable healthcare"=>"treating more minorities" seems lacking.
If you don't believe the section about minorities, then you are pulling a denial of science that is far worse than any climate science denier. There are two 'canonical' heterozygous recessive diseases that are covered in every high school biology textbook - cystic fibrosis and sickle cell anemia. Sickle cell anemia affects mostly people of west african descent. Cystic fibrosis mostly affects people of askenazi jewish descent. Sometimes I wonder why do we have high standards of care and treatment protocols, and are racing toward a cure for CF, while sickle cell anemia even has, an admittedly crude, known treatment (for a decade now) that still has languished in regulation. Why don't we have better research on SCA to figure out how to treat it?